focus -WSS

focus

author：leisure time 2025-09-29 01:46:26 - browse：175

Jacob S. Van Naarden (left), Athena Countouriotis( center), and Vlad Coric (right) on stage at the 2023 STAT Summit. — From left, Eli Lilly's Jacob S. Van Naarden, Avenzo's Athena Countouriotis, and Biohaven's Vlad Coric on stage at the 2023 STAT Summit. STAT

What does it feel like to run a biotech startup and then get “the call” — the one from the big pharma CEO who wants to acquire your company for billions of dollars?

At the 2023 STAT Summit on Wednesday, senior biotech writer Adam Feuerstein posed this question to three people very qualified to answer it: Vlad Coric, chairman and CEO of Biohaven, which was acquired by Pfizer in 2022 for $11.6 billion; Jacob Van Naarden, former COO of Loxo Oncology, which was acquired by Eli Lilly (where Van Naarden is now executive vice president) for $8 billion in 2019; and Athena Countouriotis, whose company Turning Point Therapeutics was acquired by BMS for $4 billion in 2022.

“Imagine you’re going through your typical day, and you get a message: Albert Bourla, chairman and CEO of Pfizer, wants to talk at six o’clock tonight,” said Coric, whose company had a successful migraine drug on the market and had just completed an IPO at the time.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： HPV vaccine, cervical cancer study delivers historic results

WSS

Cardiologists urge adding sexual orientation, gender identity to health records

There's an unseen cost to disruptive road

Dog Aging Project founders on what lies ahead after losing funding

RSV shot was 90% effective at preventing hospitalizations in kids

Head of FDA's diagnostics center, who led through Covid, retires

Amylyx ALS drug fails large clinical trial

knowledge

focus

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

Medicare drug price lawsuits could be good politics for Biden

23andMe had bad news about my health. I wish a person had delivered it

NEJM study link tiny plastics in blood vessels to heart problems

Virginia high school admissions case could be legal follow

Former medical device CEO who sold dummy, plastic parts convicted of fraud

New air purifier tech could be key to improving indoor air quality

What causes osteoarthritis? Researchers study link to brain protein

At least 13 dead in Texas as scorching temps continue

Update the Apgar Score to remove skin color

Wikipedia

Medicare bonuses could stop drug shortages under Senate plan

Printout prescription drug information shouldn’t go digital

Sen. Paul opposes bill to ban Chinese biotechs

FDA sets aggressive timeline for overhauling inspection procedures

CDC marks new Covid

Headspace, Meta partner to launch VR meditation app for Quest

hotspot

Wikipedia

leisure time

explore